442 related articles for article (PubMed ID: 25784130)
1. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
5. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
7. Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction.
Park JY; Lee SH; Shin MJ; Hwang GS
PLoS One; 2015; 10(8):e0135228. PubMed ID: 26258408
[TBL] [Abstract][Full Text] [Related]
8. Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Zhao YY; Cheng XL; Wei F; Xiao XY; Sun WJ; Zhang Y; Lin RC
Biomarkers; 2012 Feb; 17(1):48-55. PubMed ID: 22133066
[TBL] [Abstract][Full Text] [Related]
9. Plasma metabolome analysis of patients with major depressive disorder.
Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
[TBL] [Abstract][Full Text] [Related]
10. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
11. Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS.
Liu X; Gao X; Zhang R; Liu Z; Shen N; Di Y; Fang T; Li H; Tian F
Clin Biochem; 2020 Aug; 82():40-50. PubMed ID: 32194037
[TBL] [Abstract][Full Text] [Related]
12. Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis.
Ogawa S; Fujii T; Koga N; Hori H; Teraishi T; Hattori K; Noda T; Higuchi T; Motohashi N; Kunugi H
J Clin Psychiatry; 2014 Sep; 75(9):e906-15. PubMed ID: 25295433
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry.
Lin CH; Su H; Hung CC; Lane HY; Shiea J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361610
[TBL] [Abstract][Full Text] [Related]
14. Metabonomic study on the antitumor effect of flavonoid derivative 3d in HepG2 cells and its action mechanism.
Gao D; Jin F; Liu H; Wang Y; Jiang Y
Talanta; 2014 Jan; 118():382-8. PubMed ID: 24274312
[TBL] [Abstract][Full Text] [Related]
15. A metabonomic study of adjuvant-induced arthritis in rats using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Qi Y; Pi Z; Liu S; Song F; Lin N; Liu Z
Mol Biosyst; 2014 Oct; 10(10):2617-25. PubMed ID: 25041942
[TBL] [Abstract][Full Text] [Related]
16. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients.
Kim EY; Lee JW; Lee MY; Kim SH; Mok HJ; Ha K; Ahn YM; Kim KP
Psychiatry Res; 2018 Jul; 265():174-182. PubMed ID: 29719272
[TBL] [Abstract][Full Text] [Related]
17. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients.
Huang HJ; Zhang AY; Cao HC; Lu HF; Wang BH; Xie Q; Xu W; Li LJ
Dig Liver Dis; 2013 Aug; 45(8):677-82. PubMed ID: 23384618
[TBL] [Abstract][Full Text] [Related]
19. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
[TBL] [Abstract][Full Text] [Related]
20. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
